PFE

JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative…

The concentrated effort to develop, manufacture and distribute vaccines as the Covid-19 pandemic began to rage across the world highlighted the importance of the supply chain and helped set…

An outside panel of experts for the Centers for Disease Control and Prevention on Thursday is scheduled to weigh whether children ages 5 to 11 should receive the newly authorized Covid-19…

U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children 5 to…

U.S. health authorities and researchers are investigating why some people who appeared to recover from Covid-19 after taking Pfizer Inc.’s antiviral pill…

The Food and Drug Administration limited the use of the Covid-19 vaccine from Johnson and Johnson after reviewing the risk of life-threatening blood clots.The…

Pfizer Inc. PFE 2.79% expects demand for its Covid-19 antiviral drug to increase as governments return to replenish their supplies and…

Overall, nearly a third of the S&P 500 are scheduled to provide their quarterly updates during the week starting Monday, according to…

The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a…

Investors in three Covid-19 vaccine makers on Thursday rejected shareholder proposals aimed at broadening global access to the shots.…